Correlation Between Blockmate Ventures and Medipharm Labs

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Blockmate Ventures and Medipharm Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Blockmate Ventures and Medipharm Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Blockmate Ventures and Medipharm Labs Corp, you can compare the effects of market volatilities on Blockmate Ventures and Medipharm Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Blockmate Ventures with a short position of Medipharm Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Blockmate Ventures and Medipharm Labs.

Diversification Opportunities for Blockmate Ventures and Medipharm Labs

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between Blockmate and Medipharm is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding Blockmate Ventures and Medipharm Labs Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medipharm Labs Corp and Blockmate Ventures is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Blockmate Ventures are associated (or correlated) with Medipharm Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medipharm Labs Corp has no effect on the direction of Blockmate Ventures i.e., Blockmate Ventures and Medipharm Labs go up and down completely randomly.

Pair Corralation between Blockmate Ventures and Medipharm Labs

Assuming the 90 days trading horizon Blockmate Ventures is expected to generate 3.39 times more return on investment than Medipharm Labs. However, Blockmate Ventures is 3.39 times more volatile than Medipharm Labs Corp. It trades about 0.21 of its potential returns per unit of risk. Medipharm Labs Corp is currently generating about -0.02 per unit of risk. If you would invest  3.00  in Blockmate Ventures on September 18, 2024 and sell it today you would earn a total of  11.00  from holding Blockmate Ventures or generate 366.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Blockmate Ventures  vs.  Medipharm Labs Corp

 Performance 
       Timeline  
Blockmate Ventures 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Blockmate Ventures are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Blockmate Ventures showed solid returns over the last few months and may actually be approaching a breakup point.
Medipharm Labs Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medipharm Labs Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Medipharm Labs is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Blockmate Ventures and Medipharm Labs Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Blockmate Ventures and Medipharm Labs

The main advantage of trading using opposite Blockmate Ventures and Medipharm Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Blockmate Ventures position performs unexpectedly, Medipharm Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medipharm Labs will offset losses from the drop in Medipharm Labs' long position.
The idea behind Blockmate Ventures and Medipharm Labs Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk